The healthcare sector witnessed a significant transformation in 2023, largely driven by the integration of artificial intelligence (AI) in patient diagnostics. This integration marks a revolutionary step in how medical professionals approach diagnosis, offering a blend of efficiency, accuracy and personalization previously unattainable.
The dawn of AI-driven diagnostics
Artificial intelligence in...
Japanese pharmaceutical company Eisai, together with Oita University in Japan, has built what could be the world's first AI model that uses data from wearable devices to predict Alzheimer's disease, the most common form of dementia.
Their research team embarked on a study to create a cost-effective, practical tool to pre-screen people suspected of developing the disease. Their findings were...
Note: Andreessen Horowitz says views expressed by its employees are their own and should not be taken as investment advice. More details at https://a16z.com/disclosures/.
As 2023 comes to a close, Jay Rughani, investment partner at Andreessen Horowitz, joined MobiHealthNews to discuss his takeaways from the year, noteworthy events, recommendations for regulators forming rules around AI in...
At the HIMSS AI in Healthcare Forum in San Diego on Dec. 14, a group of panelists outlined tactical pathways to artificial intelligence adoption and investment, including how to maximize impact and decisions around adopting existing tools or building new AI infrastructure.
Anne Snowdon, CEO of Scan Health and chief research officer at HIMSS, said that determining strategic priorities and setting...
The emergence of artificial intelligence (AI) in healthcare is the result of increased demand for tailored healthcare solutions, lower costs, higher accuracy pertaining to medical decisions and diagnosis to improve patient health outcomes.
With an estimated valuation of $15.1 billion for the global market in 2022, AI in healthcare is an irreversible process that is already reshaping medicine and...
Absci, a startup focused on developing generative AI antibody discovery technology, announced a potential $247 million partnership with pharma giant AstraZeneca to focus on expediting the discovery of novel cancer treatments with the help of genAI technology.
The project will leverage Absci's Integrated Drug Creation platform – which combines scalable wet lab technologies with AI, and facilitates...
Shareholders of KOSDAQ-listed Lunit have recently participated in the company's recent capital raise, paying-in $150 million to fund its development of "next-generation" products and further expansion in the West.
Meanwhile, the AI cancer diagnostics solutions provider obtained its third 510(k) clearance from the United States Food and Drug Administration.
WHAT IT'S FOR
In a company disclosure,...
Melbourne-based health tech startup Heidi Health has raised A$10 million ($6.5 million) in a Series A funding round led by Blackbird Ventures.
Hostplus, Hesta, Wormhole Capital, Archangel Ventures, Possible Ventures and Saniel Ventures also participated in this investing round.
This brings its total investments to date to A$15 million ($9.7 million); Blackbird Ventures also led its seed funding...
Indian dermatology startup Clinikally has raised $2.6 million in a recent funding round attended by Y Combinator, Tribe Capital, Goodwater Capital, Sequoia Scout Fund, Rebel Fund and some angel investors.
Launched in 2021, the digital health company runs a web-based teledermatology platform. It provides prescription-grade hair and skin products from its partners and offers door-to-door delivery...
GE HealthCare announced a strategic partnership with Mayo Clinic dubbed the Strategic Collaboration for Innovation in Medical Imaging and Theranostics, through which the pair will collaborate on research and product development focusing on precision care, AI and theranostics.
Technology developers, clinicians, scientists and other providers from both companies will work together to advance...
